TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.

Stephen M Ansell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.